Dissecting the CMS Best Price Rule: What it Means for Manufacturer Co-Pay Programs

Mercalis in Motion
01/07/2021 28 min
Dissecting the CMS Best Price Rule: What it Means for Manufacturer Co-Pay Programs

Listen "Dissecting the CMS Best Price Rule: What it Means for Manufacturer Co-Pay Programs"

Descargar episodio

Episode Synopsis

In this podcast, Jason Zemcik, Sr. Director of Product Management at TrialCard, breaks down the implications of this rule, outlines strategies for manufacturers to address it, and provides insight on other drug pricing policy matters that could affect how manufacturers deliver patient support programs going forward..

More episodes of the podcast Mercalis in Motion

Mercalis Celebrates National Nurses Week 2025 07/05/2025
Optimizing HCP Engagement: Strategies for Every Stage of the Product Life Cycle 25/03/2025
Mercalis Executive Leadership Reflects on 2024 Successes and Future Strategy 04/03/2025
Lessons on Employee Engagement, Culture, and Inclusivity in the Post-Pandemic Workplace 17/01/2025
2024 in Review: Noteworthy Guests and Key Discussions 20/12/2024
Biosimilars and their Impact on Pharma Patient Support Services 25/11/2024
Mercalis Celebrates 15 Years of RxStudy Card 29/08/2024
Simplifying eServices with Mercalis’s Curator Solution 27/08/2024
The Mercalis Nurse Network 13/06/2024
Market Trends, AI Strategy, and More: A Conversation With Policy Reporter by Mercalis 14/05/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA